Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 hours agoSince then, the stock has pulled back. The vaccine is based on protein technology, differentiating...
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 5 days agoModerna (NASDAQ: MRNA) is best known for its work in the coronavirus vaccine market. That's why the...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 1 hour agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
GAMMA Investing LLC Purchases 822 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 2 days agoGAMMA Investing LLC grew its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 37.8% in the first quarter, HoldingsChannel reports. The fund owned 2,994 shares ...
Moderna stock is lone omen of bird flu pandemic
Reuters· 4 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 4 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the...
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Wellington Management Group LLP
ETF DAILY NEWS· 5 days agoWellington Management Group LLP lifted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.8% in the 4th quarter, according to the company in its most ...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks· 5 days agoFree Report) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the preceding day's closing price. Coming into today, shares of the biotechnology company had gained ...